457 related articles for article (PubMed ID: 34415486)
1. The Beneficial Role of Exercise on Treating Alzheimer's Disease by Inhibiting β-Amyloid Peptide.
Tan ZX; Dong F; Wu LY; Feng YS; Zhang F
Mol Neurobiol; 2021 Nov; 58(11):5890-5906. PubMed ID: 34415486
[TBL] [Abstract][Full Text] [Related]
2. Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?
Jodeiri Farshbaf M; Ghaedi K; Megraw TL; Curtiss J; Shirani Faradonbeh M; Vaziri P; Nasr-Esfahani MH
Neuromolecular Med; 2016 Mar; 18(1):1-15. PubMed ID: 26611102
[TBL] [Abstract][Full Text] [Related]
3. Treadmill exercise decreases amyloid-β burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer's disease.
Koo JH; Kang EB; Oh YS; Yang DS; Cho JY
Exp Neurol; 2017 Feb; 288():142-152. PubMed ID: 27889467
[TBL] [Abstract][Full Text] [Related]
4. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
5. Treadmill exercise decreases β-amyloid burden in APP/PS1 transgenic mice involving regulation of the unfolded protein response.
Xia J; Li B; Yin L; Zhao N; Yan Q; Xu B
Neurosci Lett; 2019 Jun; 703():125-131. PubMed ID: 30905823
[TBL] [Abstract][Full Text] [Related]
6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
7. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
8. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model.
Um HS; Kang EB; Leem YH; Cho IH; Yang CH; Chae KR; Hwang DY; Cho JY
Int J Mol Med; 2008 Oct; 22(4):529-39. PubMed ID: 18813861
[TBL] [Abstract][Full Text] [Related]
9. Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP.
Nigam SM; Xu S; Kritikou JS; Marosi K; Brodin L; Mattson MP
J Neurochem; 2017 Jul; 142(2):286-296. PubMed ID: 28382744
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
11. Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway.
Azimi M; Gharakhanlou R; Naghdi N; Khodadadi D; Heysieattalab S
Peptides; 2018 Apr; 102():78-88. PubMed ID: 29309801
[TBL] [Abstract][Full Text] [Related]
12. Electroacupuncture Improves Clearance of Amyloid-
Liang PZ; Li L; Zhang YN; Shen Y; Zhang LL; Zhou J; Wang ZJ; Wang S; Yang S
Neural Plast; 2021; 2021():9960304. PubMed ID: 34484327
[TBL] [Abstract][Full Text] [Related]
13. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
Ma WH; Chen AF; Xie XY; Huang YS
Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.
Silva CS; Eira J; Ribeiro CA; Oliveira Â; Sousa MM; Cardoso I; Liz MA
Neurobiol Aging; 2017 Nov; 59():10-14. PubMed ID: 28780366
[TBL] [Abstract][Full Text] [Related]
15. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
Bian Z; Yamashita T; Shi X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Omote Y; Morihara R; Abe K
Brain Res; 2021 Sep; 1767():147569. PubMed ID: 34197775
[TBL] [Abstract][Full Text] [Related]
16. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
17. A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy.
Wan Y; Liang Y; Liang F; Shen N; Shinozuka K; Yu JT; Ran C; Quan Q; Tanzi RE; Zhang C
J Alzheimers Dis; 2019; 72(3):761-771. PubMed ID: 31640096
[TBL] [Abstract][Full Text] [Related]
18. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy.
Joshi G; Gan KA; Johnson DA; Johnson JA
Neurobiol Aging; 2015 Feb; 36(2):664-79. PubMed ID: 25316599
[TBL] [Abstract][Full Text] [Related]
19. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
Zhang J; Guo Y; Wang Y; Song L; Zhang R; Du Y
Neurosci Lett; 2018 Feb; 666():70-77. PubMed ID: 29246793
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
